IDEVAX

📍 Antwerp, Belgium🗓 Founded 2020👥 7 employees💰 Last funded Oct 2024
Medical Equipment Manufacturing🌐 idevax.com
Website LinkedIn
VAX-ID®, the heart of the Idevax company, is an award-winning patented drug delivery device platform suited for intradermal injection. The device can be preconfigured with a 32G needle as well as with a 27G needle to allow for different applications, with a penetration depth of 0.85 and 1.2mm respectively. The device is suited for accurate and reliable drug delivery of therapeutic and prophylactic medicinal substances in the dermal layer of the skin of both humans and animals.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in IDEVAX?
IDEVAX has 1 investor on record on gritt.io, 1 mid-stage.
When did IDEVAX last raise funding?
The most recent investment in IDEVAX recorded on gritt.io was in October 2024.
When was IDEVAX founded?
IDEVAX was founded in 2020.
What industry is IDEVAX in?
IDEVAX operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is IDEVAX based?
IDEVAX is headquartered in Antwerp, Belgium.